bioRxiv Science⌕ Search

bioRxiv · 10.1101/2022.03.02.482608

Modeling of individual neurophysiological brain connectivity

Abstract

IntroductionComputational models are often used to assess how functional connectivity (FC) patterns emerge from neuronal population dynamics and anatomical connections in the brain. However, group averaged data is often used in this context and it remains unclear whether individual predictions of FC patterns using this approach can be made. Here, we assess the value of using individualized structural data for simulation of individual whole-brain FC. MethodsThe Jansen and Rit neural mass model was employed, where masses were coupled using individual structural connectivity (SC) obtained from diffusion weighted imaging. Simulated FC was correlated to individual magnetoencephalography-derived empirical FC. FC was estimated using both phase-based (phase lag index (PLI), phase locking value (PLV)) and amplitude-based (amplitude envelope correlation (AEC)) metrics to analyze the goodness-of-fit of different metrics for individual predictions. Prediction of individual FC was compared against the prediction of group averaged FC. We further tested whether SC of a different participant could equally well predict a participants FC pattern. ResultsThe AEC provided a significantly better match between individually simulated and empirical FC than phase-based metrics. Simulations with individual SC provided higher correlations between simulated and empirical FC compared to using the group-averaged SC. However, using SC from other participants resulted in similar correlations between simulated and empirical FC compared to using participants own SC. DiscussionThis work underlines the added value of FC simulations based on individual instead of group-averaged SC, and could aid in a better understanding of mechanisms underlying individual functional network trajectories in neurological disease. Impact statementIn this work, we investigated how well individual empirical functional connectivity can be simulated using the individuals structural connectivity matrix combined with neural mass modeling. Our research highlights the potential added value of using individual simulations of functional connectivity, and could aid in a better understanding of mechanisms underlying individual functional network trajectories in neurological disease. Moreover, individualized prediction of disease trajectories could enhance patient care and may provide better treatment options.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kulik, S. D., Douw, L., van Dellen, E., Steenwijk, M. D., Geurts, J. J., Stam, K. J., Hillebrand, A., Schoonheim, M. M., Tewarie, P.. 2022-03-02. Modeling of individual neurophysiological brain connectivity. https://doi.org/10.1101/2022.03.02.482608

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗